Cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy: Edited by George Mortsyn and Wiliam Sheridan (New York: Cambridge University Press, 1996

Por Panoskaltsis, Nicki, Rosenblatt, Joseph D.
Publicado em 1998

B cell regulation of the anti-tumor response and role in carcinogenesis

Por Schwartz, Marc, Zhang, Yu, Rosenblatt, Joseph D.
Publicado no J Immunother Cancer (2016)

Tumor Immunogenicity and Responsiveness to Cancer Vaccine Therapy; The State of The Art

Por Schreiber, Taylor H., Raez, Luis, Rosenblatt, Joseph D., Podack, Eckhard R.
Publicado em 2010

Tumor induced suppression of CTL expansion and subjugation by gp96-Ig vaccination

Por Schreiber, Taylor H., Deyev, Vadim V., Rosenblatt, Joseph D., Podack, Eckhard R.
Publicado em 2009

Interleukin-4 Distinctively Modifies Responses of Germinal Center-like and Activated B-cell-like Diffuse Large B-cell Lymphomas to Immuno-chemotherapy

Por Sarosiek, Kristopher A., Nechushtan, Hovav, Lu, Xiaoqing, Rosenblatt, Joseph D., Lossos, Izidore S
Publicado em 2009

Recurrent Thrombotic Thrombocytopenic Purpura-Like Syndrome as a Paraneoplastic Phenomenon in Malignant Peritoneal Mesothelioma: A Case Report and Review of the Literature

Por Socola, Francisco, Loaiza-Bonilla, Arturo, Bustinza-Linares, Ernesto, Correa, Ricardo, Rosenblatt, Joseph D.
Publicado em 2012

Clofazimine Enteropathy: A Rare and Underrecognized Complication of Mycobacterial Therapy

Por Szeto, Winnie, Garcia-Buitrago, Monica T., Abbo, Lilian, Rosenblatt, Joseph D., Moshiree, Baharak, Morris, Michele I.
Publicado no Open Forum Infect Dis (2016)

Mutation of the Methylated tRNA [Formula: see text] Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1

Por Renda, Matthew J., Rosenblatt, Joseph D., Klimatcheva, Ekaterina, Demeter, Lisa M., Bambara, Robert A., Planelles, Vicente
Publicado em 2001

Statewide Cancer Clinical Trial Navigation Service

Por Moffitt, Karen, Brogan, Frank, Brown, Clarence, Kasper, Michael, Rosenblatt, Joseph, Smallridge, Robert, Sullivan, Daniel, Kromrey, Jeffrey
Publicado em 2010

Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement

Por Al Bayati, Ahmed, Plate, Thomas, Al Bayati, Mahmood, Yan, Yaohong, Lavi, Efrat Saraf, Rosenblatt, Joseph D.
Publicado no Mayo Clin Proc Innov Qual Outcomes (2018)

Brentuximab Vedotin in Transplant-Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies

Por Forero-Torres, Andres, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L., Rosenblatt, Joseph D., Kennedy, Dana A., Younes, Anas
Publicado em 2012

Model for in vivo progression of tumors based on co-evolving cell population and vasculature

Por Choe, Sehyo C., Zhao, Guannan, Zhao, Zhenyuan, Rosenblatt, Joseph D., Cho, Hyun-Mi, Shin, Seung-Uon, Johnson, Neil F.
Publicado em 2011

Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall

Por Algashaamy, Khaled, Tan, Yaohong, Mackrides, Nicolas, Alencar, Alvaro, Peng, Jing-Hong, Rosenblatt, Joseph, Alderuccio, Juan P, Lossos, Izidore S., Vega, Francisco, Chapman, Jennifer
Publicado no Case Rep Hematol (2018)

Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma

Por Hosein, Peter J., Sandoval-Sus, Jose D., Goodman, Deborah, Arteaga, Alexandra Gomez, Reis, Isildinha, Hoffman, James, Stefanovic, Alexandra, Rosenblatt, Joseph D., Lossos, Izidore S.
Publicado no Am J Hematol (2015)

Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses

Por Zhang, Yu, Morgan, Richard, Chen, Chuan, Cai, Yancheng, Clark, Emily, Khan, Wasif Noor, Shin, Seung-Uon, Cho, Hyun-Mi, Al Bayati, Ahmed, Pimentel, Augustin, Rosenblatt, Joseph D.
Publicado no Int Immunol (2016)

Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements

Por White, Sarah M., Renda, Matthew, Nam, Na-Yon, Klimatcheva, Ekaterina, Zhu, Yonghong, Fisk, Jennifer, Halterman, Mark, Rimel, Bobbie J., Federoff, Howard, Pandya, Snehal, Rosenblatt, Joseph D., Planelles, Vicente
Publicado em 1999

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Por Chen, Robert, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Huebner, Dirk, Fong, Abraham, Younes, Anas
Publicado no Blood (2016)

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Por Gopal, Ajay K., Chen, Robert, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Chi, Xuedong, Sievers, Eric L., Younes, Anas
Publicado no Blood (2015)

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

Por Bartlett, Nancy L, Chen, Robert, Fanale, Michelle A, Brice, Pauline, Gopal, Ajay, Smith, Scott E, Advani, Ranjana, Matous, Jeffrey V, Ramchandren, Radhakrishnan, Rosenblatt, Joseph D, Huebner, Dirk, Levine, Pamela, Grove, Laurie, Forero-Torres, Andres
Publicado em 2014

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Por Pro, Barbara, Advani, Ranjana, Brice, Pauline, Bartlett, Nancy L., Rosenblatt, Joseph D., Illidge, Tim, Matous, Jeffrey, Ramchandren, Radhakrishnan, Fanale, Michelle, Connors, Joseph M., Fenton, Keenan, Huebner, Dirk, Pinelli, Juan M., Kennedy, Dana A., Shustov, Andrei
Publicado no Blood (2017)